Ailin Lepletier, PhD

With 10+ years of experience in immunology and translational research, I support biotech and research teams developing immunotherapy and vaccine strategies with strong preclinical and clinical relevance. My work focuses on T cell biology, autoimmune complications of infection, and translational pathways for immunology-led therapies. Dr. Lepletier is a Research Fellow at Griffith University’s Institute for Biomedicine and Glycomics, where she leads research on immunotherapies with a particular focus on rheumatic fever and rheumatic heart disease linked to Streptococcus pyogenes. She has also contributed to vaccine development programs that have progressed into clinical trials. Public profiles and interviews highlight her publications, grant funding, and work spanning immunotherapy, infectious disease, cancer, and autoimmunity, making her a strong fit for teams needing scientific depth plus translational execution.